Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_19-cv-00977/USCOURTS-cand-3_19-cv-00977-0/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 28:2201 Declaratory Judgement

---

AMENDED STIPULATION AND [PROPOSED] ORDER STAYING DISCOVERY AND DISCLOSURES

Case No. 3:19-cv-00977-RS 

pa-1893676 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

ERIK J. OLSON (CA SBN 175815) 

EJOlson@mofo.com 

ERIC C. PAI (CA SBN 247604) 

EPai@mofo.com 

MORRISON & FOERSTER LLP 

755 Page Mill Road 

Palo Alto, California 94304-1018 

Telephone: (650) 813.5600 

Facsimile: (650) 494.0792 

Attorneys for Plaintiff 

SANDOZ INC. 

Vernon M. Winters (SBN 130128) 

Sue Wang (SBN 286247) 

SIDLEY AUSTIN LLP 

555 California Street, Suite 2000 

San Francisco, CA 94104-1503 

Telephone: (415) 772-1200 

Facsimile: (415) 772-7400 

vwinters@sidley.com 

Nicholas Groombridge (pro hac vice) 

Eric A. Stone (pro hac vice) 

Jennifer H. Wu (pro hac vice) 

PAUL, WEISS, RIFKIND, WHARTON & 

GARRISON LLP 

1285 Avenue of the Americas 

New York, NY 10019-6064 

Telephone: (212) 373-3000 

Facsimile: (212) 757-3990 

ngroombridge@paulweiss.com 

Wendy A. Whiteford (SBN 150283) 

Lois M. Kwasigroch (SBN 130159) 

AMGEN INC. 

One Amgen Center Drive 

Thousand Oaks, CA 91320-1789 

Telephone: (805) 447-1000 

Facsimile: (805) 447-1010 

wendy@amgen.com 

Attorneys for Defendants 

AMGEN INC. and AMGEN 

MANUFACTURING, LIMITED 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

SANDOZ INC., 

Plaintiff, 

v. 

AMGEN INC. and AMGEN 

MANUFACTURING, LIMITED, 

Defendants. 

Case No. 3:19-cv-00977-RS 

AMENDED STIPULATION AND 

ORDER STAYING DISCOVERY 

AND DISCLOSURES 

Case 3:19-cv-00977-RS Document 25 Filed 05/03/19 Page 1 of 3
AMENDED STIPULATION AND [PROPOSED] ORDER STAYING DISCOVERY AND DISCLOSURES

Case No. 3:19-cv-00977-RS 

1 

pa-1893676

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

Pursuant to Civil Local Rule 7-12, Plaintiff Sandoz Inc. (“Sandoz”) and Defendants 

Amgen Inc. and Amgen Manufacturing, Limited (collectively, “Amgen”), through their 

undersigned counsel, hereby stipulate as follows: 

WHEREAS, Sandoz filed a Complaint for Declaratory Judgment of Patent 

Noninfringement and Invalidity (ECF No. 1) with respect to Sandoz’s biosimilar filgrastim and 

pegfilgrastim products on February 21, 2019; 

WHEREAS, Amgen filed a Motion to Dismiss (ECF No. 22) on April 24, 2019; 

WHEREAS, Sandoz intends to oppose the Motion to Dismiss; 

WHEREAS, the parties agree that it would promote judicial economy and conserve the 

resources of the Court and the parties to defer discovery and disclosures until after the Motion to 

Dismiss is resolved; 

NOW, THEREFORE, the parties hereby stipulate and request that the Court stay 

discovery and disclosures as follows: 

1. While the Motion to Dismiss is pending, all deadlines shall be stayed for: (a)

responding to discovery requests pursuant to Fed. R. Civ. P. 26 through 37; (b) initial disclosures 

pursuant to Fed. R. Civ. P. 26(a)(1); and (c) contentions and disclosures pursuant to Patent Local 

Rules 3-1 through 3-9. 

2. If the Motion to Dismiss is denied, the parties shall promptly meet and confer on a

schedule for completing the stayed discovery and disclosures, with the deadlines for disclosures 

and contentions beginning no later than 30 days after the ruling on the Motion to Dismiss. The 

parties shall submit their proposed schedule to the Court within 10 days after the ruling on the 

Motion to Dismiss. 

Dated: May 1, 2019 MORRISON & FOERSTER LLP 

By: /s/ Erik J. Olson 

Erik J. Olson 

Attorneys for Plaintiff 

SANDOZ INC. 

Case 3:19-cv-00977-RS Document 25 Filed 05/03/19 Page 2 of 3
AMENDED STIPULATION AND [PROPOSED] ORDER STAYING DISCOVERY AND DISCLOSURES

Case No. 3:19-cv-00977-RS. 2

pa-1893676 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

SIGNATURE ATTESTATION 

Pursuant to Civil Local Rule 5-1(i)(3), I hereby certify that concurrence in the filing of 

this document has been obtained from each of the other Signatories shown above. 

PURSUANT TO STIPULATION, IT IS SO ORDERED. 

Dated: ___________, 2019 

THE HONORABLE RICHARD SEEBORG 

UNITED STATES DISTRICT COURT JUDGE 

Dated: May 1, 2019 PAUL, WEISS, RIFKIND, WHARTON & 

GARRISON LLP 

By: /s/ Nicholas Groombridge 

Nicholas Groombridge 

Attorneys for Defendants 

AMGEN INC. and AMGEN 

MANUFACTURING, LIMITED 

Dated: May 1, 2019 By: /s/ Erik J. Olson 

Erik J. Olson 

May 3

Case 3:19-cv-00977-RS Document 25 Filed 05/03/19 Page 3 of 3